| Synthesis and biological evaluation of novel 1, 2, 3-triazole derivatives as anti-tubercular agents AA Ali, D Gogoi, AK Chaliha, AK Buragohain, P Trivedi, PJ Saikia, ... Bioorganic & Medicinal Chemistry Letters 27 (16), 3698-3703, 2017 | 81 | 2017 |
| A simple work-up-free, solvent-free approach to novel amino acid linked 1, 4-disubstituted 1, 2, 3-triazoles as potent antituberculosis agents A Garg, D Borah, P Trivedi, D Gogoi, AK Chaliha, AA Ali, D Chetia, ... ACS omega 5 (46), 29830-29837, 2020 | 34 | 2020 |
| 3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors D Gogoi, VJ Baruah, AK Chaliha, BB Kakoti, D Sarma, AK Buragohain Journal of Theoretical Biology 411, 68-80, 2016 | 19 | 2016 |
| Identification of novel human renin inhibitors through a combined approach of pharmacophore modelling, molecular DFT analysis and in silico screening D Gogoi, VJ Baruah, AK Chaliha, BB Kakoti, D Sarma, AK Buragohain Computational biology and chemistry 69, 28-40, 2017 | 13 | 2017 |
| An Unexplored Lewis Acidic Catalytic System for Synthesis of Pyrazole and its Biaryls Derivatives with Antimicrobial Activities through Cycloaddition‐Iodination‐Suzuki Reaction M Konwar, P Phukan, AK Chaliha, AK Buragohain, K Damarla, D Gogoi, ... ChemistrySelect 4 (35), 10236-10245, 2019 | 12 | 2019 |
| An in silico approach for identification of potential anti-mycobacterial targets of vasicine and related chemical compounds A Kashyap Chaliha, D Gogoi, P Chetia, D Sarma, A Kumar Buragohain Combinatorial chemistry & high throughput screening 19 (1), 14-24, 2016 | 11 | 2016 |
| Design and synthesis of quinazolinone-triazole hybrids as potent anti-tubercular agents A Dutta, P Trivedi, PS Gehlot, D Gogoi, R Hazarika, P Chetia, A Kumar, ... ACS Applied Bio Materials 5 (9), 4413-4424, 2022 | 9 | 2022 |
| Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues D Gogoi, AK Chaliha, D Sarma, BB Kakoti, AK Buragohain Biomedicine & Pharmacotherapy 85, 646-657, 2017 | 9 | 2017 |
| Identification of potential type 4 cAMP phosphodiesterase inhibitors via 3D pharmacophore modeling, virtual screening, DFT and structural bioisostere design D Gogoi, AK Chaliha, D Sarma, BB Kakoti, AK Buragohain Medicinal Chemistry Research 26, 3000-3014, 2017 | 5 | 2017 |
| GM tea: the need of the hour to reclaim India’ s leading position in the global tea market D Borah, AK Chaliha, D Gogoi, RNS Yadav Journal of Commercial Biotechnology 20 (3), 2014 | 1 | 2014 |
| Factor Receptor-2 (HER2), Journal of Theoretical Biology D Gogoi, VJ Baruah, AK Chaliha, BB Kakoti, D Sarma, AK Buragohain, ... | | 2016 |
| New ebola vaccine trial starts in humans-but how safe is it? DB Debajit Borah, VS Vandana Singh, AK Chaliha, DG Dhrubajyoti Gogoi, ... | | 2015 |
| New Ebola Vaccine Trial Starts in Humans-But how Safe is It? D Borah, V Singh, AK Chaliha, D Gogoi, N Mohamedkassm Current Science, 10-11, 2015 | | 2015 |
| New ebola vaccine trial starts in humans-but how safe is it? B Debajit, S Vandana, AK Chaliha, G Dhrubajyoti, N Mohamedkassm Current Science 108 (1), 2015 | | 2015 |
